Categories
News

Global Gene Therapy Market 2020: Growth, Latest Trend Analysis and Forecast 2025

Global Gene Therapy Market Research Report 2020: COVID-19 Outbreak Impact Analysis

Brand Essence Market Research has developed a concise study on the Gene Therapy market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline.

Download Sample PDF (including full TOC, Tables, and Figures) of Gene Therapy Market Research 2020-2026:- https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72699&RequestType=Sample

Global Gene therapy market is valued at USD 0.67 Billion in 2018 and expected to reach USD 5.18 Billion by 2025 with the CAGR of 33.9 % over the forecast period. Increasing prevalence of the cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure is further driving Gene therapy market.

Scope of Gene therapy market Report:

Gene Therapy is associated with the experimental technique that uses genes to treat or prevent disease. In the future, this system could permit doctors to treat a condition by inserting a gene into patient’s cells rather than exploitation medication or surgery. Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve body’s ability to fight disease. Gene therapy holds potential for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS. For example, suppose a brain tumor is forming by rapidly isolating cancer cells.

Global gene therapy market report is segmented on the basis of Therapy type, Vector Type, application, and regional& country level. Based upon Therapy type, gene therapy market is classified as somatic and germline. Based upon Vector type Gene Therapy Market is classified into non-viral vectors and viral vectors. Based upon Application Gene therapy market is classified into Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others.

The regions covered in this Global Gene therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Gene therapy is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Gene therapy Market Reports–
Global Gene therapy market Report covers prominent players are like Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene.

Increasing prevalence of cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure is expected to grow Gene therapy market. Growing prevalence of cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure coupled with the increasing application of public health and clinical facilities is expected to drive Gene therapy market. As this therapy is transforming the current approaches to promote the excellence in health and prevent from cardiovascular diseases such as cancer and diabetes. In 2017, it is projected that around 14% (more than 34 million adults) were current smokers. While People with diabetes comprise 8.8% of the world’s population and IDF predicted that the number of cases of diabetes will rise to 642 million by 2040. In low-income countries, mainly in Africa, the older population faces a considerable burden of both non-communicable and communicable diseases. High cost of gene therapy treatment and unwanted immune responses such factors hindering the growth of gene therapy market. Technological Advancements leading to provide better technological procedures is the lucrative opportunity for gene therapy market in forecast period.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Gene Therapy Market.

Key Benefits for Gene Therapy Market Reports
• Global market report covers in-depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in market place.
• Global market report covers extensive analysis of emerging trends and competitive landscape.

Gene Therapy Market Segmentation:

By Disease Indication
• Cancer
• Genetic disorders
• Cardiovascular diseases
• Ophthalmology
• Neurological conditions
• Others

By Type of Vectors
• Viral vectors
• Non-viral vectors

By Type of Cells
• Somatic cells
• Germline cells

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o France
o Germany
o Russia
o Rest of Europe
• Asia-Pacific
o China
o South Korea
o India
o Japan
o Rest of Asia-Pacific
• LAMEA
o Latin America
o Middle East
o Africa

North America is dominating the Gene therapy Market North America is dominating the gene therapy market during the forecast period due to increasing healthcare expenditure coupled with advancement of technologies. The majority of gene therapies clinical trials recognized targeted cancer diseases. In the US, around 66.81% of gene therapy clinical trials are carried out. While all other countries participated in a small percentage of the trials such as 9.45% in the UK, 3.95% in Germany and around 2% each in Switzerland, France, China, and Japan. Globally, regeneration medicine companies providing Gene cell therapy and tissue engineering for therapeutic developers is expected to grow gene therapy market in this region.

Gene Therapy Market Key Players:
• Pfizer Inc.
• Novartis AG
• Bayer AG
• Sanofi
• GlaxoSmithKline plc.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• uniQure N.V.
• bluebird bio, Inc.
• Celgene Corporation
• Others

This comprehensive report will provide:

• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?

>>>>Get Full Customize report  @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72699&RequestType=Customization

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

The Essential Content Covered in the Global Gene Therapy Market Report:

* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size

The report provides a 6-year forecast (2020-2026) assessed based on how the Gene Therapy market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Gene Therapy market.

Chapter 2: Evaluating the leading manufacturers of the global Gene Therapy market which consists of its revenue, sales, and price of the products.

Chapter 3:  the competitive nature among key manufacturers, with market share, revenue, and sales.

Chapter 4: Presenting global Gene Therapy market by regions, market share and revenue and sales for the projected period.

Chapters 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Read More: https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Gene-Therapy-Market-Share/Summary

About us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [email protected] 

Top Trending Reports:

https://www.marketwatch.com/press-release/air-conditioning-market-latest-innovations-statistics-analysis-by-key-players-overview-component-industry-revenue-and-forecast-to-2025-2020-09-09?tesla=y

https://www.marketwatch.com/press-release/animal-feed-micronutrients-market-global-trends-market-share-industry-size-growth-opportunities-and-market-forecast-2020-to-2025-2020-09-09?tesla=y

https://www.marketwatch.com/press-release/advanced-composites-market-global-industry-analysis-and-opportunity-assessment-2020-2025-2020-09-09?tesla=y

https://www.marketwatch.com/press-release/dental-equipment-market-size-by-growth-scenario-2020—trend-analysis-industry-status-by-manufacturers-business-share-future-scope-and-global-opportunities-forecast-to-2025-2020-09-29?tesla=y

https://www.marketwatch.com/press-release/calcium-hypochlorite-market-size-2020-by-global-business-trends-share-future-demand-progress-insight-analysis-statistics-regional-growth-and-forecast-to-2025-2020-09-09?tesla=y

Categories
Market Reports News

Gene Therapy Market Detailed Analysis 2019-2024: Amgen, Inc, Biogen, Novartis AG, Gilead Sciences, Inc and Others.

ReportsnReports offers a latest published report on “Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region – Global Forecast to 2024” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 129 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Download Free Brochure at https://www.reportsnreports.com/contacts/requestsample.aspx?name=2871629

The Global Gene Therapy Market is projected to reach US$ 13.0 Billion by 2024 from US$ 3.8 Billion in 2019, at a CAGR of 27.8% during the forecast period.

Top Companies profiled in the Gene Therapy Market:

  • Amgen, Inc. (US)
  • Biogen (US)
  • Novartis AG (Switzerland)
  • Gilead Sciences, Inc. (US)
  • Spark Therapeutics, Inc. (US)
  • MolMed S.p.A. (Italy)
  • Orchard Therapeutics plc. (UK)
  • SiBiono GeneTech Co.,Ltd. (China)
  • Alnylam Pharmaceuticals, Inc. (US)
  • Human Stem Cells Institute (Russia)
  • AnGes,Inc. (Japan)
  • Dynavax Technologies (US)
  • Jazz Pharmaceuticals, Inc. (Ireland)
  • Akcea Therapeutics (US)
  • bluebird bio, Inc. (US)
  • uniQure NV(Netherlands)
  • AGTC (US)
  • Mustang Bio (US)
  • Cellectis (France)
  • Poseida Therapeutics, Inc. (US)
  • Sangamo Therapeutics (US)

“Neurological diseases segment accounted for the largest share of the gene therapy market, by indication, in 2018”

Based on indication, the market is segmented into neurological diseases, cancer, hepatological diseases, Duchenne muscular dystrophy, and other indications. The neurological diseases segment accounted for the largest share of the market in 2018.

“Viral vectors segment to register the highest growth in the gene therapy market during the forecast period”

The gene therapy market, by vector, has been segmented into viral and non-viral vectors. In 2018, the non-viral vectors segment accounted for the largest share of this market. However, the viral vectors segment is estimated to grow at the highest CAGR during the forecast period, primarily due to the increasing demand for CAR T-based gene therapies and the rising incidence of cancer.

Browse 127 Tables and 25 Figures, 20 Companies, spread across 129 pages available at https://www.reportsnreports.com/contacts/discount.aspx?name=2871629

Table of Contents in this report:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Limitation

1.6 Stakeholders

2 Research Methodology

2.1 Research Data

2.2 Secondary Data

2.2.1 Secondary Source

2.3 Primary Data

2.4 Market Size Estimation

2.4.1 Bottom-Up Approach

2.4.2 Bottom-Up Approach for Non-Viral Vectors and Viral Vectors Market

2.4.3 Growth Forecast

2.5 Market Breakdown and Data Triangulation

2.6 Assumptions for the Study

3 Executive Summary

….And More

Avail 25% Discount on this research report at https://www.reportsnreports.com/purchase.aspx?name=2871629

Categories
News

Gene Therapy Market Forecast to 2027 – Covid-19 Impact and Global Analysis – By Cell Type (Somatic Gene Therapy, Germline Gene Therapy)

Gene therapy is the introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of a disease, causing mutations. Gene therapy is a promising treatment for genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is a suitable treatment for infectious diseases, inherited disease and cancer.

The Insight Partners provides you global research analysis on “Gene Therapy Market” and forecast to 2027. The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the Gene Therapy Market during the forecast period, i.e., 2020–2027.

>> We’ve incorporated a complete guide to create a reliable forecast — rather than a wish-cast. Get Sample Copy of Gene Therapy Market report @ https://www.theinsightpartners.com/sample/TIPHE100001165/

What’s Included in Gene Therapy Market Report:

  • Market Dynamics
  • Competitive Analysis
  • Market Trends And Market Outlook
  • Market Share And Market Size
  • Opportunities And Customer Analysis
  • Product Pricing Research

Gene Therapy Market Players:

The report focuses on leading Gene Therapy industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Sangamo Therapeutics, Inc.
  •  bluebird bio, Inc.
  •  uniQure N.V.
  •  AveXis, Inc.
  •  Vineti
  •  Solid Biosciences.
  •  Spark Therapeutics, Inc.
  •  CHIMERON BIO
  •  RENOVA THERAPEUTICS
  •  HORAMA S.A.

Reasons To Buy This Report

  • Highlights key business priorities to assist companies realign their business strategies.
  • Features key findings and crucial progressive industry trends in the global Gene Therapy market, thereby allowing players to develop effective long-term strategies.
  • Develops/modifies business expansion plans by using substantial growth offering from developed and emerging markets.
  • Scrutinizes in-depth market trends as well as key market drivers and restraints.
  • Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Gene Therapy Industry.

Interested in purchasing this Report?  Click here @ https://www.theinsightpartners.com/buy/TIPHE100001165/

Gene Therapy Market Segmented by Region/Country:

  • North America
  • Europe
  • Asia Pacific
  • Central & South America

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in Gene Therapy market study.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]